These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9413231)

  • 41. Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues.
    Grayston JT; Jackson LA; Kennedy WJ; Kronmal RA
    Am Heart J; 1999 Nov; 138(5 Pt 2):S545-9. PubMed ID: 10539871
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chlamydia: diagnostic and treatment].
    Jaton K; Greub G
    Rev Med Suisse; 2005 Mar; 1(13):895-8, 901-3. PubMed ID: 15895932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Electron microscopy, Chlamydia pneumoniae and atherosclerosis].
    Ramos Calvo PM; Ortega Higuera F; Samaniego Olano J; Díaz de Otazu R
    Med Clin (Barc); 1999 Feb; 112(7):277-8. PubMed ID: 10220758
    [No Abstract]   [Full Text] [Related]  

  • 44. Animal models of chlamydia and atherosclerosis.
    Muhlestein JB
    Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862
    [No Abstract]   [Full Text] [Related]  

  • 45. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlamydia pneumoniae pneumonia: role of new macrolides.
    Blasi F; Cosentini R; Tarsia P; Camusso L; Campi E; Arosio C; Allegra L
    J Chemother; 1995 Nov; 7 Suppl 4():117-8. PubMed ID: 8904128
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chlamydia pneumoniae: an agent involved in the pathogenesis of asthma].
    Perpiñá Tordera M; de Diego Damiá A
    Rev Clin Esp; 1998 Sep; 198 Suppl 1():24-9. PubMed ID: 9835770
    [No Abstract]   [Full Text] [Related]  

  • 48. Mouse models of Chlamydia pneumoniae infection and atherosclerosis.
    Campbell LA; Kuo Cc
    Am Heart J; 1999 Nov; 138(5 Pt 2):S516-8. PubMed ID: 10539863
    [No Abstract]   [Full Text] [Related]  

  • 49. Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
    Cook PJ
    J Antimicrob Chemother; 1999 Aug; 44(2):145-8. PubMed ID: 10473220
    [No Abstract]   [Full Text] [Related]  

  • 50. A review of Chlamydia pneumoniae and atherosclerosis.
    Lindholt JS; Fasting H; Henneberg EW; Ostergaard L
    Eur J Vasc Endovasc Surg; 1999 Apr; 17(4):283-9. PubMed ID: 10204048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antibiotic treatment of coronary disease--towards a change of paradigm?].
    Kolmos HJ
    Ugeskr Laeger; 1997 Sep; 159(37):5539-41. PubMed ID: 9312927
    [No Abstract]   [Full Text] [Related]  

  • 53. [Infection hypothesis of coronary heart disease].
    Jahn J; Hellmann I; Kothe H; Maass M; Dalhoff K; Katus HA
    Wien Med Wochenschr; 2001; 151(24):594-9. PubMed ID: 11820176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chlamydia pneumoniae: an etiologic of coronary heart disease?].
    Podsiadły E; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 1999; 53(3-4):231-43. PubMed ID: 10800561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotics in the prevention of heart attacks.
    Danesh J
    Lancet; 2005 Jan 29-Feb 4; 365(9457):365-7. PubMed ID: 15680439
    [No Abstract]   [Full Text] [Related]  

  • 56. [Atherosclerosis as an infectious disease].
    Visseren FL; Erkelens DW
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):291-5. PubMed ID: 10221083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does Chlamydia pneumoniae have a role in atherosclerosis?
    Byers J; Robertson R
    JAAPA; 2002 May; 15(5):50-2, 55-7. PubMed ID: 12063818
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chlamydia pneumoniae and its relation with human atherosclerosis].
    Gutiérrez J; Linares-Palomino J; Rodríguez M; Maroto MC
    Rev Invest Clin; 2000; 52(5):482-6. PubMed ID: 11195174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.